Title : Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.

Pub. Date : 2012 May

PMID : 22245891






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib induced a significant increase in circulating VEGF and decrease in circulating VEGFR levels. vandetanib vascular endothelial growth factor A Homo sapiens